While targeting TNF α can be beneficial, it also presents challenges. Blocking TNF α can impair the immune response, increasing the risk of infections and malignancies. Therefore, understanding the balance between beneficial and harmful effects is crucial in the development of TNF α-targeted therapies. Researchers are continually exploring ways to selectively inhibit TNF α without compromising immune function.
